Nicolau Syndrome in Patient Following Diclofenac Administration: A Case Report by Kim, Kwang-Kyoun
Nicolau Syndrome in Patient Following Diclofenac Administration: A Case Report
Vol. 23, No. 4, 2011 501
Received June 7, 2010, Revised December 3, 2010, Accepted for 
publication December 3, 2010
Corresponding author: Kwang-Kyoun Kim, M.D., Ph.D., Department of 
Orthopedic Surgery, College of Medicine, Konyang University, 685 
Gasuwon-dong, Seo-gu, Daejeon 302-718, Korea. Tel: 82-42-600-6902,
Fax: 82-42-545-2373, E-mail: ajouos@hanmail.net
This is an Open Access article distributed under the terms of the 
Creative Commons Attribution Non-Commercial License (http:// 
creativecommons.org/licenses/by-nc/3.0) which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Ann Dermatol Vol. 23, No. 4, 2011 http://dx.doi.org/10.5021/ad.2011.23.4.501
CASE REPORT
Nicolau Syndrome in Patient Following Diclofenac 
Administration: A Case Report
Kwang-Kyoun Kim, M.D., Ph.D.
Department of Orthopedic Surgery, Konyang University College of Medicine, Daejeon, Korea
Nicolau syndrome is a rare adverse reaction to a variety of 
intra-muscular drug preparations. The typical presentation is 
pain around the injection site soon after injection, followed 
by erythema, livedoid patch, hemorrhagic patch, and finally, 
necrosis of skin, subcutaneous fat, and muscle tissue. The 
phenomenon has been related to the administration of a 
variety of drugs, including non-steroidal anti-inflammatory 
drugs, corticosteroids, and penicillin. We report a case with 
typical features associated with diclofenac injection for pain 
control in a patient who had undergone bilateral total knee 
arthroplasty. (Ann Dermatol 23(4) 501∼503, 2011)
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INTRODUCTION
Nicolau syndrome is a rare adverse drug reaction that 
occurs at the site an intramuscular injection. It was first 
described in the 1920s in a patient treated with bismuth 
salts for syphilis
1,2. The phenomenon has been related to 
the intramuscular administration of a variety of drugs, 
including non-steroidal anti-inflammatory drugs (NSAIDs), 
corticosteroids, and penicillin. Histologic findings include 
thrombosis of vessels in the reticular dermis. Patients who 
undergo total knee arthroplasty experience severe pain 
postoperatively, so surgeons frequently prescribe NSAIDs, 
which are administered intramuscularly, for pain control. 
We report a patient with typical features of Nicolau 
syndrome following diclofenac injection who underwent 
bilateral total knee arthroplasty.
CASE REPORT
A 69-year-old moderately obese woman (77 kg, 157 cm) 
underwent bilateral simultaneous total knee arthroplasty. 
Her body mass index was 31.2 kg/m
2, and she had a 
medical history of diabetes and hypertension. She was 
being discharged the following day, and her progress was 
good. The night before discharge, immediately after the 
diclofenac injection, the patient complained of intense 
pain in her right buttock. The skin was swollen and 
showed diffuse redness, with blanching at the injection 
site. The next morning, the area around the injection site 
was exquisitely tender to palpation. The skin showed 
erythematous maculae and a livedoid violaceous patch 
with dendritic extensions. The initial differential diagnosis 
included allergic reaction to the diclofenac, acute blee-
ding, hematoma, and acute compartment syndrome. On 
the second day post-injection, her skin turned dark purple 
with a hemorrhagic patch. By the 10
th day post-injection, 
the erythematic area had decreased, but most of the darkly 
colored skin had progressively turned black. Two weeks 
later, the black skin had changed into an eschar (Fig. 1). 
Three weeks later, when the progression had stopped, we 
persuaded her to undergo surgical debridement of the 
necrotic tissue. We preoperatively checked the computed 
tomography (CT) scan to define the extent of the lesion, 
muscular involvement, hematoma, and fluid collection. 
CT scan revealed only diffuse infiltration into the sub-
cutaneous adipose tissue at the injection site. The muscles 
had been spared, and no liquid had collected under the KK Kim
502 Ann Dermatol
Fig. 1. Photography of right gluteal lesion three weeks post 
injection illustrating the nature and extent of the eschar.
Fig. 3. Two months later, the defect appeared completely healed,
with a small depressed scar.
Fig. 2. Post gadolinium enhanced computed tomography (CT) 
scan. The CT scan image showed an enhanced subcutaneous
infiltration in the right buttock. There was no evidence of 
underlying muscle involvement, hematoma, or acute bleeding.
eschar (Fig. 2).
The first debridement was performed across an area 20× 
14 cm and confirmed that the necrosis extended to the 
patient’s skin and subcutaneous fat, but the underlying 
muscles were intact. We covered the defect with a 
full-thickness skin graft. Two months later, the lesion had 
healed, leaving only a residual scar (Fig. 3). 
DISCUSSION
No tool or test exists for making a confirmative diagnosis 
of Nicolau syndrome; it is based purely on the clinical 
features and their correlation with previous case reports. 
One report suggests that laboratory tests reveal creatine 
kinase and myoglobin as well as other markers of muscle 
damage
3, but that author thought that a mere increase in 
creatine kinase and myoglobin does not automatically 
mean necrosis with muscle involvement. In addition, our 
patient experienced no increase in creatine kinase or 
myoglobin.
Necrotic ulcers usually heal in several months, leaving an 
atrophic scar. However, transient or permanent ischemia 
of the ipsilateral limb and various neurological compli-
cations sometimes develop
4. Our patient’s lesion rapidly 
progressed to extensive necrosis and, despite conservative 
therapy, needed surgical reconstruction. Diclofenac is a 
cyclooxygenase inhibitor and thus shares the pharma-
codynamic properties of NSAIDs, with inhibition of pro-
staglandin synthesis resulting in the vasoconstrictive 
phenomenon. In this case, injection of diclofenac was 
followed by the application of a cool pack that could 
mediate additional local vasospasm in the context of 
arterial narrowing. We suggest that both mechanisms 
contributed in a detrimentally synergistic fashion to the 
magnitude of her acute vasospasm. That might be the 
reason for the rapid progression to necrosis of our 
patient’s lesion.
Experimental studies have disproven the original hypo-
thesis of Nicolau syndrome’s allergic and immunologic 
origins. Most significantly, a patient’s reinjection with the 
agent that caused Nicolau syndrome has not induced 
recurrence
1. Our patient had received intramuscular 
diclofenac before and after the development of Nicolau 
syndrome, but the adverse reaction did not recur. Several 
theories exist. First, an intra-arterial, periarterial, or 
perinervous injection might produce intense local pain 
and a secondary vasospasm owing to sympathetic nerve 
stimulation, leading to ischemia with subsequent mus-
cular and/or cutaneous necrosis. Second, an inadvertent 
intra-arterial injection of solutions intended for intra-
muscular use might cause embolic occlusion of small skin 
arteries. Third, vascular or perivascular injection might 
produce marked inflammation and progressive necrosis of Nicolau Syndrome in Patient Following Diclofenac Administration: A Case Report
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the intima, destroying the whole arterial wall and causing 
necrosis of the skin. 
Subcutaneous instead of intramuscular injection was an 
important contributing factor in several reports
5-7. 
Cockshott et al.
6 highlighted the difficulties of admini-
stering intramuscular injections. Only 5% of females and 
15% of males can receive a gluteal injection with a 
standard 3.5 cm needle. Okan and Canter
7 described sub-
cutaneous injection and injury to cutaneous arteries, 
leading to subcutaneous fat and skin necrosis. In our case, 
the injection could have been subcutaneous due to her 
obesity and difficulty in position change. CT scan 
demonstrated only diffuse infiltration in the adipose tissue 
at the injection site. A sufficiently long needle for an 
obese patient, the Z-track method of intramuscular 
injection, injection only after aspiration with a syringe, 
and an injection in the upper outer quadrant of the gluteal 
region, which has few large blood vessels, can minimize 
subcutaneous irritation. 
In our case, it was difficult to differentiate Nicolau 
syndrome from acute compartment syndrome, which 
presents with severe pain, pallor, and swelling. In acute 
compartment syndrome, treatment is early surgical 
decompression within 12 hours to prevent irreversible 
changes of nerve and muscle. CT is a useful tool for 
differentiation. In acute compartment syndrome, there is 
hematoma or fluid collection on the buttock.
Although physicians have recognized rapid vasoactive 
therapy with subcutaneous heparin as beneficial, no 
specific therapy for Nicolau syndrome exists other than 
prevention. Clinicians should be aware of this com-
plication and avoid unnecessary intramuscular drug 
injections. Finally, physicians should consider Nicolau 
syndrome as a diagnostic possibility for anyone presenting 
with severe localized pain following an intramuscular 
injection of any substance. 
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